Compare the commitment your firm is buying
Exclusive and shared describe distribution. Qualification describes screening, while lead, transfer, and signed case describe the delivery stage. Ask for each dimension separately so one product label does not silently stand in for another.
An exclusive inquiry can still require your team to contact the person and complete intake. A shared inquiry can still include screening against a stated profile. The table identifies what to compare without assuming a standard package or recipient count.
| Buying question | Exclusive arrangement | Shared arrangement |
|---|---|---|
| Who can receive it? | Confirm the permitted recipient and any exceptions. | Confirm the recipient limit or distribution rule and parties covered. |
| What is restricted? | Identify whether the restriction covers a submission, person, incident, or matter. | Identify which information or matter may be sent to multiple recipients. |
| How does timing work? | Define when exclusivity starts, ends, or changes. | Define whether distribution is simultaneous, sequential, or otherwise scheduled. |
| What has already happened? | Ask whether earlier distribution is disclosed and what the commitment covers going forward. | Ask what prior or subsequent distribution information is available. |
| What intake work remains? | Confirm the screening and delivery stage separately. | Confirm the screening and delivery stage separately. |
| How is an exception resolved? | Agree the records and process for a claimed breach or duplicate. | Agree the process for recipient-limit, timing, or duplicate disputes. |
Exclusive vs. shared MVA leads: what changes for the same accident?
An exclusive MVA lead carries the provider’s agreed restriction on distributing that car-accident inquiry or matter. A shared MVA lead may go to multiple firms under the provider’s stated rules. Compare the recipient limit, timing, prior distribution and repeat-submission policy, then confirm the screening and intake work included.
For a car-accident inquiry, define whether exclusivity follows the form submission, the prospective client or the specific accident. In a fictional example, someone submits form A on Monday and form B about the same crash on Thursday. Your agreement should explain whether B is a duplicate, a new billable unit or a record covered by the original restriction. A different accident involving the same person needs its own review under the agreed definition.
A signed MVA handoff adds a representation-agreement stage. It does not answer the distribution question. Agree the retainer, recipient restriction and remaining firm review separately. CaseLead can scope acquisition, telephone qualification, human intake and retainer coordination around your firm’s requirements; exclusivity and remedies belong in the written proposal.
Name the parties and events that change the restriction
Identify which supplier entities and distribution partners are covered by the commitment. Ask who is responsible for investigating a routing question and what record supports the answer. A statement about one part of the acquisition chain does not describe every participant’s responsibilities.
Record the start, duration, and any event that changes the restriction. These may include a decline, failed contact, a pause, or termination, depending on the proposed terms. Intake needs to know if an action or missed deadline changes how a matter may be distributed.
Illustrative example: a proposal allows redistribution after the firm declines. Confirm what counts as a decline and who can record it. An automated acknowledgment or an unanswered follow-up should not accidentally be treated as that decision unless the agreed process expressly makes it so.
Ask about prior distribution and independent inquiries separately
An exclusive arrangement going forward does not answer whether the provider previously sent the inquiry elsewhere. Ask what earlier handling is disclosed, how it is recorded, and whether that history meets your buying requirement.
The prospective client’s own activity is another question. A person may independently contact several firms. Keep that reported activity separate from evidence about the supplier’s distribution. Neither a statement that someone called another firm nor an exclusive label alone establishes what the provider actually did.
Bring a short terms worksheet into procurement
Before approval, record the answers in one place and point to the agreement or proposal version supporting them. Use the worksheet to surface open decisions rather than fill gaps with assumptions.
- Covered unit: the submission, person, incident, or other defined matter.
- Permitted recipients: the recipient limit and the identity or category covered.
- Bound parties: the supplier and relevant distribution partners.
- Timing: start, duration, sequence, and events that change the restriction.
- Prior distribution: required disclosures and the record supplied at handoff.
- Duplicates: matching criteria, treatment of resubmissions, and billable status.
- Exceptions: review owner, supporting records, deadline, and agreed remedy.
Match either arrangement to your intake process
For a shared offer, ask how recipient limits and distribution timing work, then assess whether your intake team can operate within that arrangement. For an exclusive offer, evaluate whether the additional restriction solves a real buying requirement. Exclusivity does not remove the need for reliable follow-up.
Compare equivalent screening and handoff stages where possible. If one offer supplies an inquiry and another includes signing, the difference in remaining work can be more consequential than the distribution label. Keep the firm’s acceptance decision separate from both delivery and signature status.
Investigate duplicate concerns using the agreed definition
When intake flags a possible duplicate, preserve the relevant identifiers, incident context, and receipt dates through the firm’s approved process. Compare the information needed to apply the agreed duplicate rule. A matching phone number can flag a review without proving the same incident; a different submission ID does not prove a new matter.
Ask the supplier to explain the routing or matching record and record the disposition. An illustrative sample during procurement can show which fields exist, while an actual dispute needs the relevant delivery record. Keep a requested credit open until confirmed, and track a replacement against the original delivery so reporting remains reconcilable.
Compare the cost after your firm reviews the MVA inquiries
A unit-price premium for exclusivity is only one part of the purchase. Compare the work delivered, remaining intake cost and number of matters your firm accepts. Keep the case profile, delivery stage and review period comparable.
Fictional completed-cohort example: both arrangements below deliver 20 screened MVA inquiries, with no pending reviews at the cutoff and no credits or additional costs included. These inputs demonstrate arithmetic; they are not current prices, CaseLead results or expected acceptance rates.
The shared example totals $6,000 divided by three accepted matters; the exclusive example totals $8,000 divided by four. Both equal $2,000 per accepted matter. Different inputs can change the decision. This example does not establish that exclusivity improves acceptance or reduces intake work.
| Cost or review measure | Shared: fictional inputs | Exclusive: fictional inputs |
|---|---|---|
| Screened inquiries delivered | 20 | 20 |
| Price per inquiry | $200 | $350 |
| Supplier charges | $4,000 | $7,000 |
| Firm intake cost included | $2,000 | $1,000 |
| Total included cost | $6,000 | $8,000 |
| Unique matters accepted by the firm | 3 | 4 |
| Pending reviews | 0 | 0 |
| Cost per accepted matter | $2,000 | $2,000 |
Questions law firms ask
Does exclusive mean the person has never contacted another law firm?
No. The provider’s distribution commitment and the person’s independent contacts are separate. Ask about prior supplier distribution and record any reported outside contacts without treating one as proof of the other.
Are shared personal injury leads always sent to the same number of firms?
Do not assume a standard recipient count. Request the limit or distribution rule, timing, and covered parties for the specific offer, including any exceptions.
Does a signed case automatically include exclusivity?
Signing and distribution are different dimensions. Confirm the recipient restriction independently of whose agreement was signed and what other work accompanies the handoff.
Is a second form submission automatically a new billable lead?
That depends on the agreed covered unit and duplicate rule. Compare the person, incident, identifiers, and prior delivery record before deciding how a repeat submission should be treated.
When is paying for exclusivity worth considering?
When the defined restriction addresses a requirement your firm values and the overall scope fits its intake process. Evaluate the commercial terms, screening, workload, and accepted-case economics together rather than treating exclusivity as a quality score.
Are exclusive MVA leads worth a higher price?
That depends on the distribution commitment your firm needs, the work included and the resulting acquisition and intake cost. Compare equivalent delivery stages and a defined review period. Exclusivity alone does not establish screening quality, signature status or firm acceptance. The fictional example above shows why the lead price alone does not settle the comparison.
Define the recipient terms your firm needs
Bring your exclusivity requirements, case profile, and intake workflow to an acquisition review for your personal injury firm.
Request a law-firm acquisition review